NewGen BioPharma Corp.
CIK 0001537274
Revenue (TTM)
$0
Q1 Mar 2017
Net Income (TTM)
−$174.8K
−25.4% YoY
Q1 Mar 2017
EPS Diluted (TTM)
—
Q1 Mar 2017
Gross Margin
—
Q1 Mar 2017
Operating Margin
—
Q1 Mar 2017
Net Margin
—
Q1 Mar 2017
Free Cash Flow (TTM)
—
Q1 Mar 2017
Cash
$0
Q1 Mar 2017
Total Debt
—
Q1 Mar 2017
Shares Outstanding
22.6M sh
Q1 Mar 2017
Revenue & Net Income
Revenue Growth (YoY)
No data available for this metric.